Clinical Trial Update: Fecal Microbiota Translantation (FMT) to Reduce Inflammation in PLWH: The Gutsy Pilot Study [Phase 2]

View source ↗

Summary

This document reports the completion of a Phase 2 pilot trial evaluating fecal microbiota transplantation to reduce inflammation in people living with HIV.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Fecal microbiota transplantation (fecal microbiota transplantation)

Snippet

Sponsor: Jean-Pierre Routy | Conditions: HIV-1-infection | Phase 2 | Status: COMPLETED